{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:30:11Z","timestamp":1772555411724,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.prp.2021.153619","type":"journal-article","created":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T20:15:06Z","timestamp":1632255306000},"page":"153619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["14-3-3\u03b6 promoted invasion and lymph node metastasis of breast invasive ductal carcinoma with HER2 overexpression"],"prefix":"10.1016","volume":"227","author":[{"given":"Dan","family":"Wan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9646-9345","authenticated-orcid":false,"given":"Yutao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junju","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2021.153619_bib1","first-page":"212","article-title":"Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.prp.2021.153619_bib2","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.prp.2021.153619_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4161\/cam.4.1.10497","article-title":"Breast cancer metastasis driven by ErbB2 and 14-3-3zeta: a division of labor","volume":"4","author":"Wang","year":"2010","journal-title":"Cell Adhes. Migr."},{"key":"10.1016\/j.prp.2021.153619_bib4","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1023\/A:1024296932670","article-title":"The 14-3-3 proteins: gene, gene expression, and function","volume":"28","author":"Takahashi","year":"2003","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.prp.2021.153619_bib5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrc1230","article-title":"The 14-3-3 cancer connection","volume":"3","author":"Hermeking","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2021.153619_bib6","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.7150\/jca.41316","article-title":"The role of YWHAZ in cancer: a maze of opportunities and challenges","volume":"11","author":"Gan","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2021.153619_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev.arplant.47.1.49","article-title":"14-3-3 PROTEINS AND SIGNAL TRANSDUCTION","volume":"47","author":"Ferl","year":"1996","journal-title":"Annu Rev. Plant Physiol. Plant Mol. Biol."},{"key":"10.1016\/j.prp.2021.153619_bib8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.omtn.2018.04.007","article-title":"The ASH1-miR-375-YWHAZ signaling axis regulates tumor properties in hepatocellular carcinoma","volume":"11","author":"Zhao","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.prp.2021.153619_bib9","first-page":"2775","article-title":"miR-451 regulates FoxO3 nuclear accumulation through Ywhaz in human colorectal cancer","volume":"7","author":"Li","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.prp.2021.153619_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yexcr.2016.08.014","article-title":"14-3-3\u03b6 promotes lung cancer cell invasion by increasing the Snail protein expression through atypical protein kinase C (aPKC)\/NF-\u03baB signaling","volume":"348","author":"Tong","year":"2016","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.prp.2021.153619_bib11","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1517\/14728222.2010.531011","article-title":"14-3-3\u03b6 as a prognostic marker and therapeutic target for cancer","volume":"14","author":"Neal","year":"2010","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.prp.2021.153619_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ccell.2014.11.025","article-title":"14-3-3\u03b6 turns TGF-\u03b2\u2019s function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2","volume":"27","author":"Xu","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2021.153619_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ccr.2009.08.010","article-title":"14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition","volume":"16","author":"Lu","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2021.153619_bib14","doi-asserted-by":"crossref","first-page":"35270","DOI":"10.18632\/oncotarget.9136","article-title":"Upregulation of lactate dehydrogenase a by 14-3-3\u03b6 leads to increased glycolysis critical for breast cancer initiation and progression","volume":"7","author":"Chang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2021.153619_bib15","first-page":"169","article-title":"[Guideline for HER2 detection in breast cancer, the 2019 version]","volume":"48","author":"Recommended by Breast Cancer Expert Panel","year":"2019","journal-title":"Zhong hua Bing. Li Xue Za Zhi"},{"key":"10.1016\/j.prp.2021.153619_bib16","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.prp.2021.153619_bib17","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1021\/acs.jmedchem.7b00574","article-title":"Modulators of 14-3-3 protein-protein interactions","volume":"61","author":"Stevers","year":"2018","journal-title":"J. Med Chem."},{"key":"10.1016\/j.prp.2021.153619_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13058-020-01277-8","article-title":"Glucocorticoid receptors are required effectors of TGF\u03b21-induced p38 MAPK signaling to advanced cancer phenotypes in triple-negative breast cancer","volume":"22","author":"Perez Kerkvliet","year":"2020","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.prp.2021.153619_bib19","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1002\/anie.201914517","article-title":"A supramolecular stabilizer of the 14-3-3\u03b6\/ER\u03b1 protein-protein interaction with a synergistic mode of action","volume":"59","author":"Gigante","year":"2020","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.prp.2021.153619_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/2159-8290.CD-11-0189","article-title":"Loss of the 14-3-3\u03c3 tumor suppressor is a critical event in ErbB2-mediated tumor progression","volume":"2","author":"Ling","year":"2012","journal-title":"Cancer Disco"},{"key":"10.1016\/j.prp.2021.153619_bib21","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.3390\/ijms20143518","article-title":"14-3-3 proteins are on the crossroads of cancer, aging, and age-related neurodegenerative disease","volume":"20","author":"Fan","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prp.2021.153619_bib22","doi-asserted-by":"crossref","first-page":"665","DOI":"10.3892\/or.2020.7898","article-title":"Enhancement of cisplatin sensitivity in human breast cancer MCF-7 cell line through BiP and 14-3-3\u03b6 co-knockdown","volume":"45","author":"Kashkoulinejad-Kouhi","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.prp.2021.153619_bib23","doi-asserted-by":"crossref","first-page":"23409","DOI":"10.1002\/jcp.28910","article-title":"NAMPT regulates PKM2 nuclear location through 14-3-3\u03b6: conferring resistance to tamoxifen in breast cancer","volume":"234","author":"Ge","year":"2019","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.prp.2021.153619_bib24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.lfs.2016.02.059","article-title":"Over-expression of miR-451a can enhance the sensitivity of breast cancer cells to tamoxifen by regulating 14-3-3\u03b6, estrogen receptor \u03b1, and autophagy","volume":"149","author":"Liu","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.prp.2021.153619_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/onc.2011.223","article-title":"Tamoxifen downregulation of miR-451 increases 14-3-3\u03b6 and promotes breast cancer cell survival and endocrine resistance","volume":"31","author":"Bergamaschi","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2021.153619_bib26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13058-019-1173-5","article-title":"Dynamically decreased miR-671-5p expression is associated with oncogenic transformation and radiochemoresistance in breast cancer","volume":"21","author":"Tan","year":"2019","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.prp.2021.153619_bib27","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/onc.2012.629","article-title":"ErbB2, FoxM1 and 14-3-3\u03b6 prime breast cancer cells for invasion in response to ionizing radiation","volume":"33","author":"Kambach","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.prp.2021.153619_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.prp.2021.153619_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu Rev. Pathol."},{"key":"10.1016\/j.prp.2021.153619_bib30","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1158\/0008-5472.CAN-07-3177","article-title":"14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling","volume":"68","author":"Danes","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2021.153619_bib31","first-page":"1654","article-title":"14-3-3\u03b6 loss impedes oncogene-induced mammary tumorigenesis and metastasis by attenuating oncogenic signaling","volume":"7","author":"Joshi","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.prp.2021.153619_bib32","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0092-8674(00)80595-4","article-title":"Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor","volume":"96","author":"Brunet","year":"1999","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.prp.2021.153619_bib33","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1158\/0008-5472.CAN-08-2765","article-title":"14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival","volume":"69","author":"Neal","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2021.153619_bib34","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1039\/C7MB00271H","article-title":"Expediting dynamics approach to understand the influence of 14-3-3\u03b6 causing metastatic cancer through the interaction of YAP1 and \u03b2-TRCP","volume":"13","author":"D","year":"2017","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.prp.2021.153619_bib35","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ccell.2015.01.005","article-title":"14-3-3\u03b6 turns TGF-\u03b2 to the dark side","volume":"27","author":"ten Dijke","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2021.153619_bib36","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13058-015-0603-2","article-title":"Tipping the balance between good and evil: aberrant 14-3-3\u03b6 expression drives oncogenic TGF-\u03b2 signaling in metastatic breast cancers","volume":"17","author":"Morrison","year":"2015","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.prp.2021.153619_bib37","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1158\/0008-5472.CAN-13-2016","article-title":"14-3-3\u03b6 orchestrates mammary tumor onset and progression via miR-221-mediated cell proliferation","volume":"74","author":"Rehman","year":"2014","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.prp.2021.153619_bib38","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.21873\/invivo.12183","article-title":"Impact of hormone receptor status on the behaviour of HER2+ breast cancer","volume":"34","author":"Kolarova","year":"2020","journal-title":"Vivo"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821002806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821002806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:46:48Z","timestamp":1759733208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033821002806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":38,"alternative-id":["S0344033821002806"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2021.153619","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"14-3-3\u03b6 promoted invasion and lymph node metastasis of breast invasive ductal carcinoma with HER2 overexpression","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2021.153619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153619"}}